产品名称 | 产品编号 | 浓度/详细参数 | CAS号 | 规格/计量单位 | 价格 | 货期 | 品牌 |
---|---|---|---|---|---|---|---|
S-Allylmercaptocysteine | S649879-10mg | ≥95% | 2281-22-3 | 10mg | ¥ 2900.9 | 期货,请咨询 | 阿拉丁 |
Seviteronel | S649868-5mg | ≥99% | 1610537-15-9 | 5mg | ¥ 3500.9 | 期货,请咨询 | 阿拉丁 |
Seviteronel | S649868-50mg | ≥99% | 1610537-15-9 | 50mg | ¥ 15000.9 | 期货,请咨询 | 阿拉丁 |
Seviteronel | S649868-2mg | ≥99% | 1610537-15-9 | 2mg | ¥ 2333.9 | 期货,请咨询 | 阿拉丁 |
Seviteronel | S649868-10mg | ≥99% | 1610537-15-9 | 10mg | ¥ 5000.9 | 期货,请咨询 | 阿拉丁 |
Seviteronel | S649868-100mg | ≥99% | 1610537-15-9 | 100mg | ¥ 21000.9 | 期货,请咨询 | 阿拉丁 |
SCH 546738 | S649861-5mg | ≥98% | 906805-42-3 | 5mg | ¥ 3200.9 | 期货,请咨询 | 阿拉丁 |
SCH 546738 | S649861-50mg | ≥98% | 906805-42-3 | 50mg | ¥ 13500.9 | 期货,请咨询 | 阿拉丁 |
SCH 546738 | S649861-10mg | ≥98% | 906805-42-3 | 10mg | ¥ 4600.9 | 期货,请咨询 | 阿拉丁 |
STAT3-IN-3 | S649834-5mg | ≥98% | 2361304-26-7 | 5mg | ¥ 3500.9 | 期货,请咨询 | 阿拉丁 |
STAT3-IN-3 | S649834-50mg | ≥98% | 2361304-26-7 | 50mg | ¥ 19500.9 | 期货,请咨询 | 阿拉丁 |
STAT3-IN-3 | S649834-25mg | ≥98% | 2361304-26-7 | 25mg | ¥ 11000.9 | 期货,请咨询 | 阿拉丁 |
STAT3-IN-3 | S649834-10mg | ≥98% | 2361304-26-7 | 10mg | ¥ 5500.9 | 期货,请咨询 | 阿拉丁 |
STAT3-IN-3 | S649834-100mg | ≥98% | 2361304-26-7 | 100mg | ¥ 35000.9 | 期货,请咨询 | 阿拉丁 |
SIM1 | S649816-5mg | ≥99% | 2719051-84-8 | 5mg | ¥ 3600.9 | 期货,请咨询 | 阿拉丁 |
SIM1 | S649816-25mg | ≥99% | 2719051-84-8 | 25mg | ¥ 12500.9 | 期货,请咨询 | 阿拉丁 |
SIM1 | S649816-10mg | ≥99% | 2719051-84-8 | 10mg | ¥ 6200.9 | 期货,请咨询 | 阿拉丁 |
Soblidotin | S649813-5mg | ≥99% | 149606-27-9 | 5mg | ¥ 3500.9 | 期货,请咨询 | 阿拉丁 |
Soblidotin | S649813-50mg | ≥99% | 149606-27-9 | 50mg | ¥ 15000.9 | 期货,请咨询 | 阿拉丁 |
Soblidotin | S649813-25mg | ≥99% | 149606-27-9 | 25mg | ¥ 10000.9 | 期货,请咨询 | 阿拉丁 |
Soblidotin | S649813-1mg | ≥99% | 149606-27-9 | 1mg | ¥ 1400.9 | 期货,请咨询 | 阿拉丁 |
Soblidotin | S649813-10mg | ≥99% | 149606-27-9 | 10mg | ¥ 5000.9 | 期货,请咨询 | 阿拉丁 |
SN38-COOH | S649811-5mg | ≥98% | 2170118-23-5 | 5mg | ¥ 2500.9 | 期货,请咨询 | 阿拉丁 |
SN38-COOH | S649811-25mg | ≥98% | 2170118-23-5 | 25mg | ¥ 7500.9 | 期货,请咨询 | 阿拉丁 |